Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

Medicine, Oncology, Treatment Planning +14

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang, Jonathan Harris, Richard Wheeler et al. · New England Journal of Medicine · 2010 · 6.5K citations · Full text

Medicine, Oncology, Carcinogenesis +9

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Anil K. Chaturvedi, Eric A. Engels, Ruth M. Pfeiffer et al. · Journal of Clinical Oncology · 2011 · 3.6K citations · Full text

Medicine, Oncology, Cancer Epidemiology +11

Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

Carole Fakhry, William H. Westra, S. Li et al. · JNCI Journal of the National Cancer Institute · 2008 · 2.8K citations · Full text

Medicine, Radiation Oncology, Chemotherapy +13

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison, Andy Trotti, Jonathan Harris et al. · The Lancet · 2018 · 1.3K citations

Medicine, Oncology, Radiation Oncology +6